Verifying the Quality of Artificial Intelligence.
Verifying the Quality of Artificial Intelligence.
Verifying the Quality of Artificial Intelligence.
Ultrasound Nonmass Lesion in BI-RADS v2025: A Primer.
Trite But True: Children Are Not Little Adults-Advancing Artificial Intelligence in Pediatric Radiology.
Negotiating the Career You Want.
WB-MRI for asymptomatic screening is growing commercially despite limited evidence, no guideline endorsement, and potential harms—overdiagnosis, false-positive workup, high costs. AJR expert panel calls for prospective trials, targeted screening, and quality standards.
Uterine fibroid embolization (UFE) had 2.5% 30-day major adverse events vs 5.4% for abdominal myomectomy (odds ratio 0.44), but 1.95x higher than hysteroscopic myomectomy (1.0%). Pooling subtypes obscures differences.
Fibroblast activation protein (FAP)-directed PET shows promise as an imaging biomarker for active tissue remodeling in nonmalignant diseases like cardiac fibrosis, vasculitis, and interstitial lung disease, but current clinical evidence remains largely exploratory.
Letter to the Editor: Commercial versus open-source artificial intelligence in paediatric imaging-closing the stratified analysis gap in a scoping review.
Super-resolution deep learning reconstruction (SR-DLR) improved edge sharpness, lesion-to-liver contrast, and conspicuity vs conventional/standard DLR in liver MRI (P<0.001), but gains in malignant lesions were modest.
Four reproducible Alzheimer's subgroups identified via brain network topology show distinct biomarker signatures and cognitive trajectories; post hoc analysis found slower decline after amyloid-targeting treatment mainly in the initiation stage.
AI-assisted triage systems and teleconsultation can improve coordination and early identification of critical patients in trauma networks, while radiology AI prioritizes abnormal findings to accelerate diagnosis. These tools should supplement, not replace, clinical decision-maki…
LR-TR Viable assignment preceded LI-RADS diagnostic criteria for local recurrence in 32.8% of HCC lesions after RFA, providing a median 5.0-month lead time (IQR 4.4–13.0) and smaller lesions (1.3 vs 2.0 cm, p<0.001).
The OVERCOME-TBI study protocol will use MRI, PET, and biosampling to identify biomarkers of neurodegeneration and gut-brain disruption in up to 160 TBI patients followed for 2–15 years post-injury.
DEIMv2-X achieved highest Macro-F1 0.538 & mAP50 0.486 for detecting interproximal caries on pediatric periapical radiographs (internal test); YOLOv11x had best recall 0.561. External validation favored YOLOv11x for Macro-F1 & precision. Incipient lesions remained challenging.
In a systematic review of 17 studies, AI-assisted CT analysis for pulmonary hypertension detection achieved AUCs of 0.66–0.99. However, studies were mostly small, retrospective, and lacked external validation, limiting immediate clinical application.
A multiphase CT angiography spot sign identified high-risk intracerebral hemorrhage: hematoma expansion occurred in 25/51 (49%) phase-1, 13/28 (46%) phase-2, and 4/9 (44%) phase-3 spots versus 12/71 (17%) with no spot sign.
In 383 Alzheimer’s Disease Neuroimaging Initiative participants, tau PET biomarkers most accurately predicted cognitive decline, matching models combining all three imaging pathology measures. Binarized biomarkers largely preserved accuracy, and imaging consistently outperformed…
A multiparametric MRI radiomics model predicted growth of incidental asymptomatic meningiomas with C-index 0.813 on external validation, beating clinical-only features by up to 0.223; a 9-point score cutoff of 5 stratified high- vs low-risk.
Deep learning BI-RADS model for breast MRI yielded an AUC of 0.767 (95% CI 0.693–0.830) vs radiologist AUC 0.913 (0.857–0.952) on external validation of 158 exams, a significant difference of 0.146 (P=0.0001). At a BI-RADS >3 threshold, it flagged 54.7% of benign exams as low-ri…
The U.S. FDA has cleared ProNova Solutions’ VIRTUE QA device, a quality assurance system for charged-particle (proton) radiation therapy, via the 510(k) premarket notification pathway.
FDA has granted 510(k) clearance to Syneris for Syneris PACS v.1.0.1.0, a picture archiving and communication system.
A habitat-based CT radiomics model predicted pathological complete response after neoadjuvant chemoimmunotherapy for non-small cell lung cancer with AUCs of 0.74 (training), 0.71 (internal), and 0.67 (external) — outperforming whole-tumor models.
In 182 patients, AI calcium scoring on non-gated chest CT agreed well with manual ECG-gated CTA: ICC 0.90 (95% CI 0.871-0.926) and 0.96 (0.943-0.968), but correlation with stenosis severity was weak-to-moderate (r=0.151-0.560).
Cystic renal mass (CRM) management should integrate malignancy probability, potential clinical harm, and patient-specific factors—beyond Bosniak classification—to reduce overtreatment of benign lesions and tailor surgery to biological aggressiveness.
Analysis Shows Insurers Undermine No Surprises Act IDR Process
X-rays reveal severe aortic calcification in dialysis patients
Blue Earth Diagnostics to Present New Research Advancing Precision Molecular Imaging at ASTRO 2026
An Invitation to RSNA 2026 from RSNA President Jeffrey Klein, MD
Remote Partnership Track Overnight/Nighthawk Radiologist Job Opening in Charlotte, North Carolina